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Juzen-Taiho-To (JTT) is well known to be one of Kampo (Japanese herbal) medicine consisted of 10 component herbs and used
for the supplemental therapy of cancer patients with remarkably success. However, the precise mechanisms by which JTT could
favorably modify the clinical conditions of cancer patients are not well deﬁned. The present study, therefore, was undertaken
to examine the possible mechanisms of JTT on prevention of cancer metastasis using experimental mouse model. JTT was well
mixed with rodent chow at concentrations of either 0.2 or 1.0%, and administered orally ad libitum, which was started 1 week
before tumor cell injection and continue throughout the experiment. Oral administration of JTT at concentration 0.2 and 1.0%
into C57BL/6 male mice signiﬁcantly inhibited tumor metastasis in lungs, which was induced by the intravenous injection of 2 ×
105 B16 melanoma cell. JTT at a concentration of 1.0% also signiﬁcantly suppressed lung metastasis of B16 melanoma cell from
hind footpad in C57BL/6 mice. In the second part of experiments, the inﬂuence of the depression of natural killer (NK) cell,
natural killer T (NKT) cell and several types of cytokines on JTT-mediated inhibition of tumor cell metastasis. Intraperitoneal
injection of anti asialo-GM1 antibody against NK cells and anti NK-1.1 monoclonal antibody (mAb) to NKT cells abrogated the
inhibitory action of JTT on lung metastasis of B16 melanoma cells. Although intraperitoneal administration of anti-IFN-γ mAb
scarcely aﬀected the inhibitory action of JTT on tumor cell metastasis, injection of amrinone, which used for IL-12 suppression,
signiﬁcantlydecreased theabilityof JTT to prevent tumorcell metastasis.These results stronglysuggestthatoraladministrationof
JTT caused increase in the production of IL-12, which is responsible for the activation of both NK cell and NKT cell, in the lungs
and results in inhibition of B16 melanoma cell metastasis in the lungs.
Digestive cancer patients generally undergo surgical therapy,
chemotherapy, radiotherapy or a combination of these treat-
ments. While the eﬀects of these treatments are signiﬁcant,
it is a fact that most patients suﬀer from side-eﬀects, such as
high fever, general fatigue, loss ofappetite, pancytopenia and
many kinds of infections.
In Japan and China, herbal medicine is used as a sup-
plemental therapy for many kinds of chronic diseases such
as loss of appetite, anemia and chilliness of the arms and legs
with remarkable success [1, 2].Recentreports clearlyshowed
that when herbal medicines are used for cancer treatment,
many patients experience fewer or diminished side-eﬀects
induced by western medicine, such as chemotherapy and
radiotherapy,andthesurvival periodislonger[3,4].Itisalso
reported that herbal medicine can prevent the progression
of colon carcinoma, gastric and breast cancer as well as the
prevention of these cancer metastasis in liver, lung or bone
[3, 4]. Moreover, hepatocellular carcinoma has been shown
to become smaller without severe side-eﬀects [5]. Although
these reports strongly suggest that herbal medicine will be a
good alternative for the treatment of several types of cancer,
the mechanisms by which herbal medicine could improve
clinical status, including cancer metastasis.
The immune system of vertebrates is composed of two
major arms: innate immunity and adoptive immunity. In-
nate immunity provides a swift response to agents prior to
the initiation of adoptive immune responses. The innate re-
sponse is almost immediate and is based on cells and soluble
mediators that recognize common molecular patterns on
pathogenic bacteria and transformed cells. Cells involved
in the innate immune responses include several types of
cells, such as macrophages, dendritic cells, natural killer
(NK) cells and natural killer T (NKT) cells. In these phago-
cytic cells, NK and NKT cells play essential roles in tumor2 Evidence-Based Complementary and Alternative Medicine
immunology: NK cells have killer activating receptors and
cause lysis of target cells using speciﬁc enzymes, perforin
and granzymes [6]. NKT cells, which are cytotoxic cells that
have characteristics of both NK cells and T cells, play a role
in searching for tumor cells, so called immune surveillance,
and in preventing metastasis [7]. From these reports, it is
reasonable to speculate that oral administration of herbal
medicine in cancer patients enhance the activity of NK and
NKTcellsand resultsin bothpreventionofcancermetastasis
and favorable modiﬁcation of clinical conditions of the
patients. However, there is no evidence showing that herbal
medicine can enhance the function of both NK and NKT
cells in vivo. The present study, therefore, was undertaken to
examine the inﬂuence of herbal medicine on NK and NKT
cells using Juzen-Taiho-To (JTT) and experimental cancer
metastatic model in mice.
1.Methods
1.1. Mice. Speciﬁc pathogen-free C57BL/6 male mice, 6-
week old, and ICR nude female mice (nu/nu; 5 weeks of age)
were purchased from Japan Bio-Supply Center (Tokyo,
Japan). The animals were maintained at 25 ± 2◦C, humidity
50 ± 2%, and a light and dark cycle of 12 h in our animal
facilities. The mice were randomly divided into groups of
ﬁve mice and fed chow containing JTT (0.2% or 1%) or
regular diet (control). This study was approved by the Ethics
Committee of Showa University for Animal Experiments.
1.2. Reagents and Antibodies. JTT was provided by Tumura
Co. Ltd. (Tokyo, Japan) as a preservative free pure powder.
JTT is composed of 10 herbs: Astragali Radix, Cinamomi
Cortex, Rehmanniae Radix, Paeoniae Radix, Cnidii Rhizoma,
Angelicae radix, Ginseng radix, Hoelen, Glycyrrhizae Radix
and Atractylodis Lanceae Rhizoma.Amrinone (SigmaChemi-
cals,StLouis,MO,USA)wasdissolvedin0.5Nlacticacidata
concentration of 5%, diluted with phosphate buﬀered saline
to the total volume of 10ml, and then sterilized by passing
through a 0.2-mm ﬁlter [8]. Anti-asialo-GM1 was obtained
from Wako Pure Chemicals (Osaka, Japan). Monoclonal
antibody (mAb) against IFN-γ was puriﬁed by ammonium
sulfate precipitation [9] from ascites collected from ICR-
nude mice inoculated with rat hybridoma R4-6A2 (kindly
donated by Dr Y. Kudo, Tohoku University, Sendai, Japan).
The mAb against NK1.1 was kindly donated from Dr N.
Watanabe (Jikei University, Tokyo, Japan).
1.3. Preparation of Diet Containing JTT. Pure powder of JTT
was well mixed with normal powder diet (MF) for main-
taining rats and mice (Oriental Kobo Kogyou Co. Ltd.,
Tokyo, Japan) at concentrations of either 0.2 or 1.0%. The
concentration of JTT in the diet (0.2%) is equivalent to the
clinical dose (7.5 g/day/50 kg) [10].
1.4. Tumor Cells. B16 melanoma cells were purchased from
Dai-Nippon Pharmaceutical Co. Ltd. (Osaka, Japan) and
maintained with RPMI-1640 medium supplemented with
10% heat inactivated fetal calf serum (Flow Laboratories,
North Ride, Australia).
1.5. Assay for Tumor Cell Metastasis. In the ﬁrst experiments,
B16 cells (2 × 105) were injected subcutaneously into the
right hind sole in a volume of 0.l ml. After tumor growth
reached ∼1cm (∼14 days after cell injection), the tumor
was removed under a dissecting microscope. These mice
were then maintained for further 21 days and the black
dots, showing tumor colony formation, on the lung surface
were counted under a dissecting microscope [11, 12]. In
the second experiments, B16 cells (2 × 105) were injected
intravenously into recipient mice in a volumeof0.1ml. After
14 days, mice were killed under ether anesthesia and the
numberoftumorcoloniesonthelungsurfacewascountedin
a similar manner. In these two experiments, mice were given
foodcontainingJTT andtapwateradlibitum for2or3weeks
starting 7 days before tumor cell injection.
1.6. Assay for Cell Cytotoxicity of JTT. B16 melanoma cells
(1 × 104 cells/ml) were introduced in triplicate into 24-well
culture plates that contained various concentrations of JTT.
The number of cells was counted with trypan blue 24 and
48h after culture.
1.7. Depression of NK Cell and NKT Cell. To depress NK
cells and NKT cells, anti-NK1.1 mAb was injected intraperi-
toneally into mice at a single dose of 10 mg/kg on Days −2,
0 ,2a n d7r e l a t i v et ot u m o rc e l li n j e c t i o n[ 13]. In a case of
NK cell depression, anti-asialo-GM1 antibody was injected
intraperitoneally into mice at a dose of 200mg/mouse 1 day
after tumor cell injection [14].
1.8. Depression of IFN-γ and IL-12. To depress IFN-γ,a n t i -
IFN-γ mAb wasinjected intomice onDays3,0,3,7,9,11,14
relativetotumorcellinjectionatasingledoseof50.0mg/day.
To suppress IL-12, amrinone was given intraperitoneally
every day from Day −1t o1 4a tas i n g l ed o s eo f1 0 0m g / d a y
[8] in a volume of 0.4 ml.
1.9. Statistical Analysis. The statistical signiﬁcance between
control and experimental groups was analyzed with analysis
of variance (ANOVA) followed by Fisher’s PLSD test. P < .05
was considered signiﬁcant.
2.Results
2.1. Suppression of B16 Melanoma Cell Metastasis by JTT.
This experiment was undertaken to examine the inﬂuence
of oral administration of JTT on tumor cell metastasis using
diﬀerent two types of experimental models. Mice pretreated
with either 0.2% or 1.0% JTT for 7 days were injected
intravenously with 2 × 105 B16 cells and were killed 14
days later to count the number of tumor cell colonies in the
lungs. As shown in Figure 1(a), oral administration of 0.2%
JTT could cause signiﬁcant suppression of B16 melanoma
cell metastasis. Furthermore, this suppressive activity of
JTT on tumor metastasis was further strengthened whenEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Inﬂuence of JTT on B16 melanoma cell metastasis in
mice. C57BL/6 mice were orally administered JTT, which was
started 1 week before injection of 2 × 105 melanoma cells and
killed 3 or 5 weeks later to count tumor cell colonies in the lungs.
(a) Number of colonies in the lungs 2 weeks after intravenous
injectionofcells.(b)Numberoftumorcoloniesinthelungs5weeks
after subcutaneous injection of cells. +P<. 05.
mice were pretreated with 1.0% JTT: the number of tumor
cell colonies observed in mice treated with 1.0% JTT was
much lower than that in 0.2% JTT-treated mice. We then
examined whether oral administration of JTT could also
prevent spontaneous tumor cell metastasis as in the case
of intravenous administration of tumor cells. As shown in
Figure 1(b), administration of 1.0% JTT into mice could
prevent spontaneous B16 melanoma cell metastasis from
right hind footpad to lung surface.
2.2. Inﬂuence of JTT on Tumor Cell Growth in vitro. The
present study was designed to determine whether JTT exerts
cytotoxic eﬀects on B16 melanoma cells and results in the
preventionoftumorcellmetastasis. AsshowninTable 1,JTT
could not suppress B16 melanoma cell growth even when
c e l l sw e r ec u l t u r e di nt h ep r e s e n c eo f2 5 %J T T :t h en u m b e r
of cells in experimental cultures observed at 48 h is almost
equal to that observed in control cultures.
2.3. Eﬀect of NK Cell and NK-1.1 Cell Depression on Tumor
Cell Metastasis in JTT-Treated Mice. This experiment was
carried out to examine the inﬂuence of NK cell and NK-1.1
cell depression on tumor cell metastasis. To do this, recipient
mice were given either anti-asialo-GM1 or anti NK-1.1mAb,
andchallenged intravenouslywith B16melanoma cells. After
14 days, the inﬂuence of cell depletion was assessed by
counting the number of tumor cell colonies on lung surface.
As shown in Figure 2, injection of anti asialo-GM into mice
Table 1: Inﬂuence of JTT on B16 melanoma cell growth in vitro.
Concentration of JTT (%) No. of cells (mean ± SD × 104 cells/ml)
24 h 48 h
0( c o n t r o l ) 3 . 5± 0.5 33.0 ± 4.0
10 4.0 ± 0.5 34.5 ± 8.3
25 4.0 ± 1.0 32.5 ± 9.3
B16melanomacells(1×104 cells/ml)wereculturedinthepresenceofeither
0, 10 or 25% JTT. Viable cells were counted with haemocytometer in the
presence of trypan blue.
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Figure 2: Inﬂuence of injection of antibodies against natural killer
or natural killer T cells on B16 melanoma cell metastasis in mice
treated with JTT. C57BL mice were orally administered with 1.0%
JTT for3weeks, which wasstarted 1week before 2 ×105 melanoma
cell injection. Anti-NK1.1 monoclonal antibody or anti-asialo-
GM1 antibody was injected intraperitoneally and number of tumor
cell colonies was counted 2 weeks later. +P<. 05, ++P<. 01.
abrogated inhibitory action of JTT on tumor cell metastasis:
the number of colonies in mice treated with antibody is
signiﬁcantly higher than that in control mice. Injection of
antiNK-1.1mAbalsoeliminated theabilityofJTT toprevent
tumor cell metastasis and higher number of colonies was
observed in mAb-treated mice as compared with control.
2.4. Tumor Cell Metastasis in Cytokine-Depressed JTT-Treated
Mice. This study was designed to examine the inﬂuence
of cytokine depression on the prevention of tuxmor cell
metastasis induced by 1.0% JTT administration. Mice were
treated with either anti IFN-γ monoclonal antibody or
amrinone and challenged with 2 × 105 tumor cells. After
14 days, mice were sacriﬁced and the number of tumor
cell colonies in the lung surface was counted. As shown in
Figure 3, injection of anti-IFN-γ mAb scarcely aﬀected the
suppressive activity of JTT on tumor cell metastasis and4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Inﬂuence of anti-IFN-γ monoclonal antibody or amri-
none injection on B16 melanoma cell metastasis in mice treated
with JTT. C57BL mice were orally administered with 1.0% JTT
for 3 weeks, which was started 1 week before 2 × 105 melanoma
cell injection. Anti-IFN-γ monoclonal antibody or amrinone was
injected intraperitoneally and number of tumor cell colonies was
counted 2 weeks later. +P<. 05.
the number of tumor cell colonies in JTT-treated, mAb-
injected mice was similar to that observed in JTT-treated,
non-mAb-injected mice. On the other hand, treatment of
mice with amrinone caused signiﬁcant suppression of the
ability of JTT to prevent tumor cell metastasis and many
metastatic nodules of the lung were observed in JTT-treated,
amrinone-injected mice compared with JTT-treated, non-
injected mice.
3.Discussion
Herbalmedicineisusedfrequentlyasasupplementaltherapy
for many kinds of chronic diseases with remarkably success
[1]. In cases of treatment for cancer, herbal medicine is
reported to be able to prevent the progression of colon
carcinoma,gastric andbreast canceraswell astheprevention
of the cancer metastasis to the liver, lung or bone [15].
However, the mechanisms by which herbal medicine could
improve clinical status of cancer patients, including cancer
metastasis. The present study, therefore, was undertaken to
examine the possible mechanisms of herbal medicine on the
prevention of cancer metastasis through the choice of JTT
and B16 melanoma cell/mouse system in vivo.W er e g a r d
JTT has an ability to prevent cancer metastasis by BRM
(biological response modiﬁerthe).
The present results showed that oral administration of
JTT inhibited B16 melanoma cell colony formation on the
lung surface, when the recipient mice were given tumor cells
intravenously (Figure 1(a)). JTT also suppressed sponta-
neous B16 tumor cell metastasis from hind footpad to the
lung surface (Figure 1(b)). The prevention of tumor cell
growth and metastasis is well accepted to be through diverse
mechanisms, including tumor cell death, apoptosis and
immune-mediated cancer regression. Our results revealed
the absenceofcytotoxiceﬀectsofJTTonB16melanomacells
(Table 1) suggesting that immune-mediated mechanisms are
responsible for the prevention of tumor cell colony forma-
tion on the lung surface. The immune eﬀector responses
against tumor cells involve activity by several cellular con-
stituents: (i) T cells carry out immunologic surveillance,
then proliferates and destroys tumor cells after recognizing
tumor-associated antigens in combination with major his-
tocompatibility complex (MHC) molecules. (ii) Dendritic
cells are important antigen presenting cells that can present
antigen to both helper and cytotoxic T cells and are able to
stimulate a na¨ ıve T cell response. (iii) NK and NKT cells
are another populations of eﬀector cells with tumoricidal
activity. In contrast to cytotoxic T cells, NK cells can kill
tumor cells in a non-MHC-dependent fashion. We, there-
fore, examined the ﬁnal eﬀector cells that cause tumor cell
killing in JTT-treated mice. The present results proved that
injection of NK-1.1 mAb and anti asialo-GM1 antibody
eliminate the suppressive activity of JTT on tumor cell
metastasis. Anti NK-1.1 mAb is reported to be the eﬀective
means of the depleting NK and NKT cells [16]. On the other
hand, injection of anti-asialo-GM1 antibody into mice only
eliminate NK cells from a variety of mouse strains [16].
Taken together, the present results may suggest that NK cells
play essential roles in prevention of tumor cells metastasis in
the lung.
Several cytokines have been shown to aﬀect NK cell pro-
liferation and cytolytic activity. Of these, IFN-γ, produced
by activated T cells and NK cells, in conjunction with other
cytokines such as IL-12, is thought to enhance the cytolytic
activity of NK cells to attach and kill tumor cells [17–19],
indicatingthatoraladministration ofJTTintomiceincreases
the levels of cytokines, including IFN-γ and IL-12 in the
lung tissues and results in prevention of tumor cell colony
formation. On the other hand, the present results also open
the question that whether IFN-γ or IL-12 is important for
the development of the ability to prevent tumor metastasis
observed in JTT-treated mice. The present results indicate
that administration of neutralizing anti-IFN-γ mAb could
not abrogate the suppressive activity of JTT on tumor cell
metastasis. However, administration of amrinone, which
cause speciﬁc suppression of IL-12 production [20], caused
complete elimination of the ability of JTT to prevent tumor
metastasis in the lung. These results strongly suggest that IL-
12 is the main mediator in the development of inhibitory
action on tumor metastasis observed in mice treated with
JTT.
Althoughthe present resultsindicatedthat JTT exertsthe
protective eﬀects on tumor cell metastasis through enhance-
ment of IL-12 production and NK cell activation, the com-
ponent of JTT which shows immuno-modulatory eﬀects, is
not deﬁned. There is evidence that oral administration of
extracts from A. radix, a component of JTT, could enhance
the ability of cells to produce several types of cytokines,
which increase NK and NKT cell activity [21, 22]. It is alsoEvidence-Based Complementary and Alternative Medicine 5
observed that A. radix directly activate NK cells to kill tu-
mor cells in vitro [22–24], suggesting that A. radix is the
most important component of JTT to prevent tumor cell
metastasis. Further experiments are required to delineate the
component, showing the suppressive activity of tumor cell
metastasis in vivo.
The conclusions re-stated are as follows: (i) JTT could
prevent tumor cell metastasis through the enhancement of
NK cell activity, and (ii) This activity of JTT may be owing,
in part, to its ability to increase in IL-12 production.
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